\
&
Contact us
This was 1 year ago
LocationEurope
ProgrammesThe European Researchers’ Night is the largest science outreach event in Europe. The 2024 edition takes place on 27 September. In 2024 and 2025, 58 projects will run events in 25 countries.
Universities and research institutes across Europe will open their doors and share their work through presentations, experiments, games, discussions and other interactive formats. It’s your chance to go behind the scenes, meet researchers from your area and discover how the seemingly abstract world of science is already affecting your everyday life.
In the Brussels Capital-Region on 27 and 28 September WiseNight will take place. On Friday, you will have a chance to engage with researchers and learn more about their work in the Planetarium. On Saturday, all activities will take place in the Museum of Natural Sciences. The event is open to all and free of charge.
Since 2022, there is a new format in town! Researchers at Schools brings leading scientists into the classroom and pupils to the lab. It complements the European Researchers’ Night and is run by the same organisers. The difference is that the activities take place throughout the year. They are specifically aimed at little researchers-to-be.
For a map with all the events and activities in all 25 countries and more information on how to partake whether as a science enthusiast, a researcher or teacher check out the MSCA and ERC news article
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Digital, Industry & Space Digital Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.